Difficulty: Medium
Average Score: 69%
Practice
A 40-year-old male with a diagnosis of moderate to severe asthma is placed on Zileuton. What is the mechanism of action of Zileuton?
Correct answer
C
Rationale
In the context of educating on the mechanism of action of Zileuton for asthma treatment, it is crucial to understand the pharmacology behind this drug. Zileuton is a 5-lipoxygenase inhibitor that works by specifically inhibiting the production of leukotrienes, which are inflammatory mediators involved in the pathogenesis of asthma.
Therefore, option C, "Inhibition of Leukotriene Production," is the correct answer. By blocking the formation of leukotrienes, Zileuton helps to reduce airway inflammation, bronchoconstriction, and mucus production in patients with asthma.
Regarding why the other options are incorrect:
A) Inhibition of Cytokine Production: While cytokines play a role in inflammation, Zileuton specifically targets leukotrienes, not cytokines.
B) Inhibition of Muscarinic Receptor action: This mechanism is targeted by anticholinergic drugs, not Zileuton, which focuses on leukotriene inhibition.
D) Inhibition of Mediator release: While leukotrienes are mediators of inflammation, Zileuton acts specifically on leukotriene production, not on general mediator release.
In an educational context, understanding the mechanism of action of respiratory drugs like Zileuton is essential for healthcare professionals to make informed decisions in managing asthma patients. It highlights the importance of targeted therapy in asthma management and the role of leukotrienes in the inflammatory process. This knowledge helps optimize treatment strategies and improve patient outcomes.
Therefore, option C, "Inhibition of Leukotriene Production," is the correct answer. By blocking the formation of leukotrienes, Zileuton helps to reduce airway inflammation, bronchoconstriction, and mucus production in patients with asthma.
Regarding why the other options are incorrect:
A) Inhibition of Cytokine Production: While cytokines play a role in inflammation, Zileuton specifically targets leukotrienes, not cytokines.
B) Inhibition of Muscarinic Receptor action: This mechanism is targeted by anticholinergic drugs, not Zileuton, which focuses on leukotriene inhibition.
D) Inhibition of Mediator release: While leukotrienes are mediators of inflammation, Zileuton acts specifically on leukotriene production, not on general mediator release.
In an educational context, understanding the mechanism of action of respiratory drugs like Zileuton is essential for healthcare professionals to make informed decisions in managing asthma patients. It highlights the importance of targeted therapy in asthma management and the role of leukotrienes in the inflammatory process. This knowledge helps optimize treatment strategies and improve patient outcomes.